SUMMARY
This is AI generated summarization, which may have errors. For context, always refer to the full article.
Bahrain has approved Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday, February 25.
The small Gulf state already offers citizens and residents free of charge 4 vaccines: the Pfizer/BioNTech, vaccine, one manufactured by Chinese state-backed pharmaceutical giant Sinopharm, the Oxford-AstraZeneca COVID-19 vaccine and Russia’s Sputnik V.
NHRA said the vaccine was for groups at greater risk of developing complications from COVID-19, including the elderly and people with chronic diseases.
“An in-depth study had been conducted on all documents submitted by the company, which included the results of the clinical trials conducted,” NHRA CEO Mariam Al-Jalahma said.
The US Food and Drug Administration said on Wednesday, February 24, the Johnson & Johnson shot appeared safe and effective in trials, paving the way for its approval for emergency use in the United States as soon as this week. – Rappler.com
Add a comment
How does this make you feel?
There are no comments yet. Add your comment to start the conversation.